Stock CANTA CANTARGIA AB
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Cantargia AB

Equities

CANTA

SE0006371126

Real-time Estimate Cboe Europe
Other stock markets
 08:42:36 2024-05-02 am EDT 		5-day change 1st Jan Change
3.371 SEK +1.05% Intraday chart for Cantargia AB -8.86% -9.79%
Apr. 17 Cantargia Publishes New Data on the Can10 Antibody, Detailing Its Interaction with IL1RAP and Functional Inhibition CI
Apr. 10 Cantargia AB Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in A Leading Scientific Journal CI

Evolution of the average Target Price on Cantargia AB

Price target over the last 5 years

History of analyst recommendation changes

9.IJur8pu1AZuFavLH79xh9-QJt8E57LzgfaXaewsf69g.Yvafh6viQMLxPceoorMspItR0PJdhcqGH_ezJHJMubZjq5zCyMw1y-RTnQ~d275b7eda6730d4d79e6dd87e748246c

Analyst Recommendations on Cantargia AB

Cantargia AB Reports High Response Rates with CAN04 Combination Therapy in NSCLC and Presents Next Development Steps CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
3.336 SEK
Average target price
12.67 SEK
Spread / Average Target
+279.70%
High Price Target
15 SEK
Spread / Highest target
+349.64%
Low Price Target
10 SEK
Spread / Lowest Target
+199.76%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CANTA Stock
  4. Consensus Cantargia AB